PLAY PODCASTS
HIV-ASSIST: A Free, Online Tool for Individualized, Evidence-Based ART Selection—Audio Recap
Episode 50

HIV-ASSIST: A Free, Online Tool for Individualized, Evidence-Based ART Selection—Audio Recap

Listen to expert insights from Ethel D. Weld, MD, PhD, on using HIV-ASSIST to guide ART selection in a patient with HIV, comorbidities, drug–drug interactions, and resistance mutations.

Decera Clinical Education Infectious Disease Podcast · Ethel D. Weld MD PhD

May 18, 202142m 29s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Ethel D. Weld, MD, PhD, demonstrates the use of HIV-ASSIST, a free, online, decision support tool to inform ART selection.

Ethel D. Weld, MD, PhD
Assistant Professor of Medicine, Pharmacology, & Molecular Sciences
Division of Clinical Pharmacology
Department of Infectious Diseases
Johns Hopkins University School of Medicine
Attending Physician
Inpatient HIV Service
General Infectious Diseases Consult Services
Johns Hopkins Hospital
Baltimore, Maryland

Content based on a CME program supported by educational grants from Gilead Sciences, Inc.; Theratechnologies; and ViiV Healthcare.

Link to full program:
https://bit.ly/33RZ9Zy


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

evg/c/ftc/tafart pill sizeboosted pitrial 1489ramse92qviking studydtg/taf/ftcbicias-usa guidelinestsepamo updategemini-1dtgtreatment-naïveviral loaddhhs guidelinesbic/ftc/taf2-drug regimenantiretroviral therapyprepramgemini-2viking-3evg/c/taf/ftcemeraldstanford databaseinstisdhhs perinatal guidelinestrial 1490dtg/abc/3tcliverpool interactionsdolphin2m194vtsepamo datadtg/ftc/tafralftc/tdfart and pregnancyresistance-associated mutationsgeminiftc/tafvirologic outcomesart and conceptionseroconversion on prepdtg/3tcpill aversionfirst-line artarthivsingle-tablet regimen